Semaglutide may be recommended for patients who: Are starting GLP-1 treatment for the first time Prefer a medication with a longer safety track record Have responded well to GLP-1 medications previously Are looking for a more gradual approach to weight loss Tirzepatide may be considered for patients who: Have plateaued on semaglutide and stopped seeing results Have higher amounts of weight to lose Haven't responded adequately to single-pathway GLP-1 medications Are candidates based on their metabolic profile (determined by physician evaluation) "The question isn't which medication is better," a MEDVi spokesperson said
Prioritize Protein at Every Meal Protein helps maintain muscle, keeps you full longer, and supports metabolism during weight loss
Lifestyle modifications paired with semaglutide therapy amplify reflux control
Its meant to be mixed into 12 to 20 ounces of water once or twice a day
Following dehydration in ascending concentrations of ethanol solutions (5 min washes in 50%, 70%, 100%, and 100% ethanol), slides were air-dried, and a hydrophobic barrier was created around the sections using a hydrophobic pen (Vector Labs)
"These findings may inform shared decision making when considering GLP- 1 receptor agonist therapy and highlight the need for further evaluation of dermatological outcomes in future studies." The study involved a large number of people: 12,004 patients using GLP-1 drugs were compared to 15,221 using SGLT-2 inhibitors, with an additional 11,964 GLP-1 users compared to 11,233 using DPP-4 inhibitors
